Frontlight ResearchEarly access
Trial site
Nihon University Itabashi Hospital
- 10running trials
- 4closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Fatty liver disease (MASLD/MASH)3 trials
- Coronary artery disease2 trials
- Heart failure2 trials
- Sjögren's disease2 trials
- Atrial fibrillation1 trial
- Chronic rhinosinusitis with nasal polyps1 trial
- Liver cirrhosis1 trial
- Multiple myeloma1 trial
- Psoriasis1 trial
- Stroke1 trial
- Phase
- Phase 311 trials
- Phase 1/21 trial
- Phase 21 trial
- Status
- Active, not recruiting6 trials
- Completed4 trials
- Recruiting4 trials
- Lead sponsor
- Janssen Research & Development, LLC5 trials
- Boehringer Ingelheim2 trials
- Alumis Inc1 trial
- Eli Lilly and Company1 trial
- Heartseed Inc.1 trial
- and 4 more
Running trials
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Phase III Study of Eque-cel in Subjects With Len-refractory RRMM (FUMANBA-03)
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
Recruiting
Active, not recruiting
Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Fatty liver disease (MASLD/MASH)2 recruiting
- Chronic rhinosinusitis with nasal polyps1 recruiting
- Heart failure1 recruiting
- Liver cirrhosis1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 15 Nov 2026